Popular / View All Posts

Journal of Drugs in Dermatology JDD Article about Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report

Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report

| Case Reports, Featured Articles, Latest News | No Comments
Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,...
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok.

JDD Re:View With Dr. Beer

| Featured Articles, JDD Re:View, Latest News | No Comments
Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have...
Journal of Drugs in Dermatology JDD Article about Scar Wars: A Review of Topical Scar Therapies

Scar Wars: A Review of Topical Scar Therapies

| Featured Articles, Latest News, Medical Derm | No Comments
Review places silicone and occlusion as first‑line topical therapy, with retinoids, pressure, corticosteroids and cannabinoids as situational tools amid limited high‑quality evidence Scarring reflects replacement of normal dermis by fibroblast-driven,...
Journal of Drugs in Dermatology JDD Article about Maximizing a Focused Vitiligo Patient Visit: A Practical Approach

Maximizing a Focused Vitiligo Patient Visit: A Practical Approach

| Case Reports, Featured Articles, Latest News, Medical Derm | No Comments
Efficient history, targeted exam, selective labs and clear shared‑decision plans let dermatologists deliver meaningful vitiligo care in time‑pressed visits In routine practice, non‑segmental vitiligo (NSV) visits can be both brief...